Author

Hyunkee Kim

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Benzodiazepine use, incident dementia and Alzheimer's disease, and progression to severe dementia: A nationwide Korean cohort study.

BackgroundThe association between benzodiazepine (BZD) use and dementia risk remains controversial owing to conflicting observational findings and incomplete adjustment for confounders.ObjectiveTo examine the association between BZD use and incident dementia, including Alzheimer's disease (AD), and to determine whether...

Hyunkee Kim, Jiyeong Kim, Ho-Jin Choi et al. · Journal of Alzheimer's Disea... · 0 citations

Open access Oct 2026

miR‐214‐3p and NCKAP1: A microglial functional dimension of Alzheimer's progression

Abstract INTRODUCTION Biological Alzheimer's disease (AD) pathology does not fully explain the marked heterogeneity in clinical severity or progression. We investigated whether patient‐derived induced microglia‐like cell (iMG) profiles capture a functional dimension of AD progression beyond conventional plasma biomarke...

Min-Young Noh, Yeonsil Moon, Sung-Woo Kang et al. · Alzheimer's & Dementia · 0 citations

Open access Jul 2026

Lecanemab in symptomatic PSEN1 p.Met233Val early‐onset Alzheimer's disease: Neuroimaging safety, regional amyloid‐PET dynamics, and longitudinal plasma biomarkers

The presenilin 1 (PSEN1) p.Met233Val variant is a Dominantly Inherited Alzheimer Network–Trials Unit (DIAN‐TU)–eligible autosomal‐dominant Alzheimer's disease (ADAD) variant for which lecanemab response data are unavailable.

Min-Young Noh, Wonjae Sung, Hyunkee Kim et al. · Alzheimer's & Dementia · 0 citations